2025
Dynamic Contrast-enhanced MRI Processing Comparison for Distinguishing True Progression From Pseudoprogression in High-grade Glioma.
Amer A, Ansari S, Krayyem A, Kundu S, Khose S, Pokhylevych H, Calle S, Patel C, Yang Z, Liu H, Johnson J. Dynamic Contrast-enhanced MRI Processing Comparison for Distinguishing True Progression From Pseudoprogression in High-grade Glioma. Journal Of Computer Assisted Tomography 2025 PMID: 39876523, DOI: 10.1097/rct.0000000000001716.Peer-Reviewed Original ResearchHigh-grade gliomasBlood-brain barrierDCE-MRIPeak contrast enhancementQuantify BBB permeabilityTreatment-related changesFollow-up subjectsKtrans mapsTrue progressionTumor progressionClinical dataConventional MRIPseudoprogressionBBB permeabilityCombined pathologyKtransContrast enhancementT1 enhancementStandard processing methodologyStatistically significant resultsClinical data setsPathologyPatientsGliomaSSS technique
2024
NEAT: Nurse Effort Assessment Tool—Human Factors Considerations in Designing for Appropriate Staffing
Good S, Boyce M, Evans L, Sevilla M. NEAT: Nurse Effort Assessment Tool—Human Factors Considerations in Designing for Appropriate Staffing. Proceedings Of The Human Factors And Ergonomics Society Annual Meeting 2024, 68: 1680-1684. DOI: 10.1177/10711813241261347.Peer-Reviewed Original ResearchElectronic health recordsPatient-level informationHealth recordsAppropriate staffingIncreased acuityPatient assessmentBehavior patientsClinical sitesAssessment toolStatistically significant resultsPatient recordsNursesSignificant resultsSubjective ratingsPatientsStaffingAlgorithmFactors considerationsRecordsScoresAutomated algorithmAssociations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments
Wallach J, Yoon S, Doernberg H, Glick L, Ciani O, Taylor R, Mooghali M, Ramachandran R, Ross J. Associations Between Surrogate Markers and Clinical Outcomes for Nononcologic Chronic Disease Treatments. JAMA 2024, 331: 1646-1654. PMID: 38648042, PMCID: PMC11036312, DOI: 10.1001/jama.2024.4175.Peer-Reviewed Original ResearchConceptsMeta-analysesChronic diseasesFood and Drug AdministrationMeta-regression analysisMeta-analyses of observational studiesSurrogate markerClinical outcomesClinical trialsMeta-analysisEvidence of associationPublished meta-analysesStrength of associationMeta-analyses of clinical trialsChronic disease treatmentFood and Drug Administration tableResults of meta-regression analysisOutcome pairsFood and Drug Administration approvalMain OutcomesData extractionSystematic reviewStatistically significant resultsObservational studyPooled analysisDrug Administration“Peace of Mind” After Mastectomy: A Scoping Review
Hamid S, Bakkila B, Schultz K, Grimshaw A, Gunderson C, Godfrey E, Lee C, Berger E, Rosenberg S, Greenup R. “Peace of Mind” After Mastectomy: A Scoping Review. Annals Of Surgical Oncology 2024, 31: 5168-5179. PMID: 38717543, DOI: 10.1245/s10434-024-15360-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsContralateral prophylactic mastectomyUnilateral mastectomyBreast-conserving therapyAverage-risk womenInclusion criteriaPsychosocial well-beingProspective cohort studyBackgroundMany womenProphylactic mastectomyScoping reviewMethodsNine databasesWhite/Caucasian womenCohort studyStudy samplePostoperative time pointsStatistically significant resultsRelevant articlesWell-beingAnxietyResultsThe inclusion criteriaWomenMastectomySignificant resultsSurgical choiceSurgical decision
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply